Journal of Medical Microbiology · 2015 · 31 citations · 58 references
MedicineOncologyPharmacologyAntimicrobial ResistanceCancer PharmacologyChemotherapyAntibiotic ResistanceBacterial ToxinsChemotherapy ResistanceCytotoxic ChemotherapyTherapeutic ResistanceAnticancer Drug ResistanceBacterial ExotoxinsCancer Cell Survival SignalingCytotoxicity AssaysPseudomonas Aeruginosa ResistanceTherapeutic Resistance Mechanisms
In patients with malignancy, the major barrier to achieving complete response is emergence of resistance to current chemotherapeutic agents. One of the major mechanisms by which tumour cells become resistant to therapies is by altering cellular drug targets through mutations and/or deletions. Resistance by this mechanism is achieved more easily if the drug has limited cellular targets and/or processes. We hypothesized that as Pseudomonas aeruginosa exotoxin T (ExoT) targets six proteins that are required for cancer cell survival and proliferation, it is highly unlikely for cancer cells to develop resistance to this toxin. We assessed ExoT's cytotoxicity against multiple invasive and highly resistant tumour cell lines in order to evaluate its potential as a chemotherapeutic agent. Our data demonstrated that ExoT induced potent cytotoxicity in all tumour cell lines that we examined. Collectively, our data highlighted the potential of ExoT as a possible chemotherapeutic candidate for the treatment of cancer.
58
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
Medicine, Oncology, Pharmacology +15
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty, J. Infante, Adil Daud et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text
Medicine, Oncology, Pharmacology +16
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Herbert D. Soule, J. Vázquez, Anna Long et al. · JNCI Journal of the National Cancer Institute · 1973 · 2.5K citations
Medicine, Cell Biology, Oncology +10
Thomas Decker, Marie‐Luise Lohmann‐Matthes · Journal of Immunological Methods · 1988 · 1.4K citations